摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

endo-9-methyl-9-azabicyclo<3.3.1>nonan-3-ol hydrochloride | 60205-58-5

中文名称
——
中文别名
——
英文名称
endo-9-methyl-9-azabicyclo<3.3.1>nonan-3-ol hydrochloride
英文别名
endo-9-methyl-9-azabicyclo[3.3.1]nonan-3-ol hydrochloride;9-Methyl-9-azabicyclo[3.3.1]nonan-3-ol hydrochloride;9-methyl-9-azabicyclo[3.3.1]nonan-3-ol;hydrochloride
endo-9-methyl-9-azabicyclo<3.3.1>nonan-3-ol hydrochloride化学式
CAS
60205-58-5
化学式
C9H17NO*ClH
mdl
——
分子量
191.701
InChiKey
HIXYALRNLOELPP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.42
  • 重原子数:
    12.0
  • 可旋转键数:
    0.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    23.47
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    endo-9-methyl-9-azabicyclo<3.3.1>nonan-3-ol hydrochloride 、 3-acetyloxy-2-(4-chlorophenyl)propanoic acid 在 盐酸氯化亚砜 作用下, 生成
    参考文献:
    名称:
    Differential analgesic activity of the enantiomers of atropine derivatives does not correlate with their muscarinic subtype selectivity
    摘要:
    The enantiomers of several tropic and p-substituted tropic acid esters related to atropine obtained by esterification under non-racemizing conditions after resolution of the corresponding racemic acids [(+)- and (-)-18, (+)- and (-)-19] are reported. They were tested in vitro on muscarinic subtype receptors and in vivo for their analgesic activity on mice. As in the case of the lead compound, R-(+)-hyoscyamine, these substances show enantioselectivity in analgesic tests, the eutomers being the R-(+) or R-(+)-p-substituted tropic acid derivatives. However, this property, which is a consequence of increased central release of ACh, seems unrelated to muscarinic subtype selectivity insofar as the compounds are unable to discriminate muscarinic subtype receptors. A possible explanation of these results which does not involve subtype selectivity is proposed, based on the recently developed concept of inverse agonism.
    DOI:
    10.1016/s0223-5234(97)83285-0
点击查看最新优质反应信息

文献信息

  • Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists
    作者:Marco Turconi、Massimo Nicola、Myrna Gil Quintero、Luciano Maiocchi、Rosella Micheletti、Ettore Giraldo、Arturo Donetti
    DOI:10.1021/jm00170a009
    日期:1990.8
    synthesized and evaluated for 5-HT3 antagonistic activity in a radioligand binding assay ([3H]ICS 205930) and in the 5-HT-induced von Bezold-Jarisch reflex in the rat. It was found that endo-substituted azabicycloalkyl derivatives (e.g. 7a, 12a, 12b) were much more active than the corresponding exo analogues (e.g. 7b, 12h, 12i) or azacycloalkyl compounds. Amidic derivatives 12a, 12b, 12c, 12e, 13b, and
    合成了一系列含有碱性氮杂环或氮杂双环烷基部分的2,3-二氢-2-氧代-1H-苯并咪唑-1-羧酸酯和酰胺,并在放射性配体结合测定中评估了其对5-HT3的拮抗活性([ 3H] ICS 205930)和5-HT诱导的大鼠von Bezold-Jarisch反射。发现内取代的氮杂双环烷基衍生物(例如7a,12a,12b)比相应的exo类似物(例如7b,12h,12i)或氮杂环烷基化合物具有更高的活性。事实证明,酰胺衍生物12a,12b,12c,12e,13b和13c的活性比相应的酯衍生物7a,11a,7c,7d,8a和8b高约10倍。特别是化合物12a(DA 6215)在结合试验中的Ki = 3.8 nM,在von Bezold-Jarisch反射试验中的ED50 = 1 nM / kg iv,活性与参考化合物2(ICS 205930,Ki = 2 nM,ED50 = 2.1 nM / kg)相当
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺